title: Photorefractive keratectomy with mitomycin-C for the treatment of compound moderate myopia with astigmatism in buccal pemphigus vulgaris.
abstract: We report a case of controlled buccal pemphigus vulgaris with compound moderate myopia with astigmatism that was treated with photorefractive keratectomy with mitomycin-C (PRK+MMC) in both eyes. The preoperative manifest refraction was -6.50 sphere and -5.5 -0.75 x 20 in the right eye and left eye, respectively, with a best corrected visual acuity of 10/10 in both eyes. Seven months after surgery, the uncorrected visual acuity was 10/10 in both eyes. The manifest refraction was 0.75 sphere and 0.50 -0.75 x 120 in the right eye and left eye, respectively. Haze was not detected in the follow-up examinations. Reepithelialization was complete 5 days after surgery in both eyes. The results show that PRK+MMC for compound moderate myopia with astigmatism in a patient with controlled pemphigus vulgaris may be an effective and safe treatment.
authors: Noor Vision Correction Center, Tehran University of Medical Sciences, Tehran, Iran. mTaheri@noorvision.com
authors: Seyed Mohammad Reza
authors: SM
authors: Taheri
authors: Azita
authors: A
authors: Kheiltash
mesh_terms: D000328:Adult; D000477:Alkylating Agents / Q000008:administration & dosage*; D001251:Astigmatism / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D054018:Lasers, Excimer; D016685:Mitomycin / Q000008:administration & dosage*; D009061:Mouth Mucosa / Q000473:pathology; D009216:Myopia / Q000601:surgery*; D010392:Pemphigus / Q000150:complications*; D018903:Photorefractive Keratectomy
chemical_list: D000477:Alkylating Agents; D016685:Mitomycin